NCBiotech News

Thermo Fisher Scientific will invest approximately $500 million and add 500 new jobs in Greenville over the next two years as it expands its sterile drug product development and commercial manufacturing of critical medicines, therapies and vaccines

Burlington-based LabCorp has received Emergency Use Authorization from the FDA to sell its COVID-19 test home collection kit, the first to be available over the counter without requiring a prescription.

Durham gene editing ag tech leader Elo Life Systems is using its proprietary computational biology pipeline to identify the genetic factors that can improve the vanilla orchid and introduce groundbreaking ways to produce more vanilla with less labor.

Antifungal therapies developer Mycovia is preparing to seek FDA approval of its first drug after the compound posted

Newly released Seqirus data demonstrate the effectiveness and safety of its pandemic influenza A (H5N1) vaccine that it makes in cell culture at its massive manufacturing facility in Holly Springs.

Southeastern North Carolina’s rural Scotland County community of Maxton is getting 10 new jobs and a $1.9 million expansion being added to the local Huvepharma factory, thanks in part to funding from NCBiotech.

Chimerix, a Durham-based biopharmaceutical company that’s developing medicines to treat cancer and other diseases, has received good regulatory news for its potential antiviral treatment for smallpox.

The United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Durham-based BioCryst Pharmaceuticals’ berotralstat a positive scientific opinion through the Early Access to Medicines Scheme.

The FDA has approved a once-daily capsule developed by Durham's BioCryst Pharmaceuticals to prevent the life-threatening attacks of swelling in people with the rare disease called hereditary angioedema, or HAE.

An NCBiotech contract drug development and manufacturing portfolio company, KBI Biopharma, will establish a new $150M, 200-employee manufacturing facility near RTP.

North Carolina’s Small Business and Technology Development Center is hosting a two-day workshop for entrepreneurs starting Wednesday, Dec. 2

Former Duke University science educator and researcher and NCBiotech board member James (Jim) Siedow, Ph.D., has died. 

Academic scientists at NC universities receive the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.

Verona Pharma has landed an additional $30 million in financing to support its “first-in-class” drug candidate, ensifentrine, targeting chronic obstructive pulmonary disease (COPD).

Eli Lilly and Durham gene editing innovator Precision Biosciences announced a research collaboration and exclusive license agreement that could potentially be worth over $2.7 billion.